Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors
Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: pralatrexate
- DRUG: fluorouracil
- OTHER: laboratory biomarker analysis
- GENETIC: DNA analysis
- OTHER: high performance liquid chromatography
- GENETIC: polymerase chain reaction
- GENETIC: nucleic acid sequencing
- OTHER: pharmacological study
- OTHER: pharmacogenomic studies
- GENETIC: polymorphism analysis
Sponsor
University of Nebraska
Collaborators